Syntometrine
Syntometrine is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Registry-listed formulations
syntometrine · mesh:C038346
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
1 source entries across 1 studies. This list may not include all unresolved or historical entries.
- SyntometrineRegistry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
0
trials recruiting
3
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Clinical Trials (3)
Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section
Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean
Intramuscular Oxytocics: A Randomised Control Trial
All 3 trials loaded
Drug Details
- Intervention Type
- Drug
- Total Trials
- 3